- Home
- IMVT vs FRME Comparison
IMVT vs FRME Comparison
Compare IMVT & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- FRME
- Stock Information
- Founded
- IMVT 2018
- FRME 1893
- Country
- IMVT United States
- FRME United States
- Employees
- IMVT N/A
- FRME N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- FRME Major Banks
- Sector
- IMVT Health Care
- FRME Finance
- Exchange
- IMVT Nasdaq
- FRME Nasdaq
- Market Cap
- IMVT 2.7B
- FRME 2.3B
- IPO Year
- IMVT N/A
- FRME N/A
- Fundamental
- Price
- IMVT $23.21
- FRME $35.87
- Analyst Decision
- IMVT Buy
- FRME Buy
- Analyst Count
- IMVT 9
- FRME 4
- Target Price
- IMVT $27.71
- FRME $47.33
- AVG Volume (30 Days)
- IMVT 2.0M
- FRME 299.4K
- Earning Date
- IMVT 11-10-2025
- FRME 10-22-2025
- Dividend Yield
- IMVT N/A
- FRME 4.04%
- EPS Growth
- IMVT N/A
- FRME 32.99
- EPS
- IMVT N/A
- FRME 4.00
- Revenue
- IMVT N/A
- FRME $649,589,000.00
- Revenue This Year
- IMVT N/A
- FRME $13.99
- Revenue Next Year
- IMVT N/A
- FRME $14.20
- P/E Ratio
- IMVT N/A
- FRME $8.90
- Revenue Growth
- IMVT N/A
- FRME 9.53
- 52 Week Low
- IMVT $12.72
- FRME $33.13
- 52 Week High
- IMVT $31.66
- FRME $46.13
- Technical
- Relative Strength Index (RSI)
- IMVT 66.40
- FRME 42.10
- Support Level
- IMVT $23.31
- FRME $34.86
- Resistance Level
- IMVT $26.17
- FRME $36.23
- Average True Range (ATR)
- IMVT 1.24
- FRME 0.81
- MACD
- IMVT 0.19
- FRME 0.03
- Stochastic Oscillator
- IMVT 61.36
- FRME 34.77
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About FRME First Merchants Corporation
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.